www.poweredbyculture.com - poweredbyCULTURE
Organize a poweredbyCULTURE community in your city LAUNCH IT
Posted 12/26/2019 by Cystic Fibrosis Foundation

Adding Tomorrows - Cystic Fibrosis Foundation

The FDA recently approved Kalydeco, the first drug to address the underlying cause of cystic fibrosis for a small segment of the CF population. Meet two children who are still in need of a lifesaving treatment for CF.